Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03617523
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:44.662913+00:00
Published At
2019-11-25T00:00:00+00:00
Record Updated At
2022-03-29
Results Posted At
2019-11-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Influenza"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-29"
protocolSection.identificationModule.nctId
"NCT03617523"
protocolSection.identificationModule.officialTitle
"Safety and Immunogenicity of Fluzone\u00ae Quadrivalent, Flublok\u00ae Quadrivalent, and Fluzone\u00ae High-Dose, Influenza Vaccines, 2018-2019 Formulations"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-11-25"

Study condition terms

  • Influenza (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.